Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: influence of modulation with leucovorin.

Author: EnckeA, HottenrottC, InglisR, LorenzM, MaierP, ReimannM

Paper Details 
Original Abstract of the Article :
Hepatic regional treatment represents an attempt to improve tumor response by increasing drug concentration with low systemic toxicities. Recently in vitro and clinical studies have shown that the cytotoxicity of 5-fluorodeoxyuridine (FUDR) and 5-fluorouracil (5FU) can be potentiated by high doses o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/1532672

データ提供:米国国立医学図書館(NLM)

Continuous Regional Treatment for Colorectal Cancer Metastases: A Journey Through the Desert of Cancer

In the vast and unforgiving desert of [colorectal cancer treatment], [regional therapy] offers a beacon of hope for patients with [liver metastases]. This study embarks on a journey to explore [the efficacy and impact of continuous regional treatment with fluoropyrimidines, specifically focusing on the modulation of treatment with leucovorin]. The authors meticulously examined [the clinical data of 221 patients] treated with [various forms of long-term monthly continuous regional treatment]. Their findings provide valuable insights into [the potential benefits and limitations of this approach].

Navigating the Shifting Sands of Treatment Options

The research demonstrates that [continuous regional treatment with fluoropyrimidines can improve survival times, particularly after liver resection], with a [median survival time of 36 months] observed in this cohort. The authors emphasize that [the response rate varies depending on factors such as the number of metastases, extent of infiltration, tumor volume, and extrahepatic disease].

The Oasis of Hope and the Challenges of Side Effects

While [regional treatment offers hope for patients with colorectal liver metastases], it's important to recognize [the potential side effects]. This study highlights [the importance of careful monitoring and management of local side effects, including biliary sclerosis and chemical hepatitis]. The authors acknowledge that [further randomized trials are necessary to compare regional treatment with systemic treatment options].

Dr.Camel's Conclusion

This research illuminates the complexities of [regional treatment for colorectal cancer metastases] and emphasizes the need for [continued research and individualized treatment strategies]. The authors' insights provide valuable guidance for clinicians in [navigating the challenges and maximizing the benefits of this approach].

Date :
  1. Date Completed 1992-05-01
  2. Date Revised 2018-05-24
Further Info :

Pubmed ID

1532672

DOI: Digital Object Identifier

0093-7754(92)90079-G

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.